The present invention is directed to hair care composition comprising from about 8 to about 17% of one or more surfactants; from about 0.01% to about 10% of one or more surfactant soluble antidandruff agents; from about 0.01% to about 5% of one or more polyacrylate or polyacrylamide based thickening polymer; from about 0.02-0.25% salicylate salts or acids; from about 0.02-0.25% benzoate salts or acids wherein there is a weight ratio of about 1:1 to 12.5:1 for the salicylate salts or acids to benzoate salts or acids.

The present invention is directed to hair care composition comprising from about 8 to about 17% of one or more surfactants; from about 0.01% to about 10% of one or more surfactant soluble antidandruff agents; from about 0.01% to about 5% of one or more polyacrylate or polyacrylamide based thickening polymer; from about 0.02-0.25% salicylate salts or acids; from about 0.02-0.25% benzoate salts or acids wherein there is a weight ratio of about 1:1 to 12.5:1 for the salicylate salts or acids to benzoate salts or acids.

Compositions of the invention contain, in a cosmetically acceptable aqueous medium, a) a cationic polyelectrolyte, b) at least one surfactant; and (c) from about 0.01 to about 1.2 weight percent of an anionic polyelectrolyte, where the weight ratio of the anionic polyelectrolyte to the cationic polyelectrolyte is from about 0.05 to about 1.2, and where the composition exhibits a viscosity change that is below a minimum significant-change-threshold (Δηmin) and exhibits no measurable yield stress or increase in yield stress value when compared to a substantially identical composition that does not contain from about 0.01 to about 1.2 weight percent of the anionic polyelectrolyte, at a weight ratio of anionic polyelectrolyte to cationic polyelectrolyte of from about 0.05 to about 1.2.

Compositions of the invention contain, in a cosmetically acceptable aqueous medium, a) a cationic polyelectrolyte, b) at least one surfactant; and (c) from about 0.01 to about 1.2 weight percent of an anionic polyelectrolyte, where the weight ratio of the anionic polyelectrolyte to the cationic polyelectrolyte is from about 0.05 to about 1.2, and where the composition exhibits a viscosity change that is below a minimum significant-change-threshold (Δηmin) and exhibits no measurable yield stress or increase in yield stress value when compared to a substantially identical composition that does not contain from about 0.01 to about 1.2 weight percent of the anionic polyelectrolyte, at a weight ratio of anionic polyelectrolyte to cationic polyelectrolyte of from about 0.05 to about 1.2.

Compositions of the present invention include an anionic surfactant, a zwitterionic surfactant, a superhydrophilic amphiphilic copolymer, an organic acid; and a polymer selected from the group consisting of a non-hydrophobically modified alkali-swellable emulsion polymer and a non-crosslinked hydrophobically modified acid-swellable emulsion polymer, wherein, when the composition contains the non-hydrophobically modified alkali-swellable emulsion polymer, the non-hydrophobically modified alkali-swellable emulsion polymer is present in an amount of about 0.1% to 5% by weight, and when the composition contains the non-crosslinked hydrophobically modified acid-swellable emulsion polymer, the non-hydrophobically modified acid-swellable emulsion polymer is present in an amount of about 0.1% to 5% by weight, and wherein the composition has an NTU value of 95 or less, a yield value of about 0.1 Pascal or more and pH of from about 3 to about 6.5.

A hair treatment agent for reducing and/or preventing the bleeding out and/or fading of artificially produced hair colors is provided herein. The hair treatment agent has a pH value in the range of from about 4 to about 5. The hair treatment agent includes, relative to the total amount of the hair treatment agent, from about 0.01 to about 10% by weight of a lanthanum and/or lanthanide salt, at least one anionic surfactant selected from the group of alkyl (ether) sulfates, sulfosuccinates, ether carboxylic acids, N-acylamino acids having 8 to 24 C atoms in the acyl group, (acyl) isethionates having 8 to 24 C atoms in the acyl group, and mixtures of these surfactants, and from about 0.01 to about 10% by weight of an organic acid selected from the group of maleic acid, lactic acid, acetic acid, propanoic acid, amino acids, and mixtures thereof.

A hair treatment agent for reducing and/or preventing the bleeding out and/or fading of artificially produced hair colors is provided herein. The hair treatment agent has a pH value in the range of from about 4 to about 5. The hair treatment agent includes, relative to the total amount of the hair treatment agent, from about 0.01 to about 10% by weight of a lanthanum and/or lanthanide salt, at least one anionic surfactant selected from the group of alkyl (ether) sulfates, sulfosuccinates, ether carboxylic acids, N-acylamino acids having 8 to 24 C atoms in the acyl group, (acyl) isethionates having 8 to 24 C atoms in the acyl group, and mixtures of these surfactants, and from about 0.01 to about 10% by weight of an organic acid selected from the group of maleic acid, lactic acid, acetic acid, propanoic acid, amino acids, and mixtures thereof.

Anhydrous hydrocolloid matrices contain one or more encapsulated therapeutic agents, including an acne agent and/or skin conditioning agent. The anhydrous hydrocolloid matrices are used as acne treatment dressings alone or in a laminate with a water-impermeable or semi-water impermeable backing and a release liner. The anhydrous hydrocolloid matrices are made using a premix of viscosity modifiers and hydrocarbon emollients and the one or more therapeutic agents, which are mixed via high shear mixing to form the premix. The resulting anhydrous hydrocolloid matrices include the one or more therapeutic agents which are encapsulated and homogeneously distributed therein.

A topical preparation for use in treating dermatological ailments is prepared from a mixture comprising salicylic acid or a salt thereof, zinc or a salt thereof, iodine or a salt thereof, and a pharmaceutically acceptable carrier vehicle. The preparation comprises any one or more of anti-inflammatory properties, keratolytic properties, anti-pruritic properties, anti-carcinogenic properties. Methods of treatment involving topical application of the preparation are also described.

A concentrated salicylic acid gel comprising salicylic acid and a stabilizer compound, wherein the salicylic acid comprises at least 30 wt % of the total weight of the gel.